Almost 50% ...

... of Medicaid beneficiaries with hepatitis C in four states — Delaware, Maryland, New Jersey and Pennsylvania — were denied coverage of new antiviral therapies, according to a study by Burman's Specialty Pharmacy and Penn Medicine.